Novelna's platform is optimized for the rapid identification and clinical validation of novel protein biomarkers, enabling us to develop a diverse array of medical tests more efficiently.
Platform
Our Approach
Our proprietary approach to biomarker discovery and panel development emphasizes agility, accuracy, and robustness. By using a multi-disease discovery design, we swiftly pinpoint the most promising panels and validate novel biomarkers using independent sample cohorts. This facilitates a rapid transition from discovery to application.
Applications of our Tests
While our platform primarily focuses on cancer, it takes a universal approach to disease detection, offering early detection solutions for a wide range of other diseases through our adaptable technology.
